Propofol versus insulin cardioplegia in valvular heart surgeries assessed by myocardial histopathology and troponin I

Mohamed, Omyma Shehata; Al-Elwany, Shady Eid; Raouf, Mina Maher; Tawfik, Heba Mohamed; Youssef, Ibrahim Abbas

doi:TEJA-2022-0178

Propofol versus insulin cardioplegia in valvular heart surgeries assessed by myocardial histopathology and troponin I

Authors

TEJA-2022-0178

Abstract

Background and Aims
Despite of the effectiveness of on pump cardiac surgeries in valvular diseases, cardioplegic arrest and myocardial reperfusion injury are still an obstacle. Many cardioprotective additives are tried but the obtained laboratory results are mixed. Our objective was to compare the effects of supplementing the cardioplegia solution with propofol or insulin evaluated not only by laboratory biomarkers but also with papillary muscle biopsy in patients undergoing on pump valvular surgeries.
Methods
Sixty adult patients were randomly assigned into three equal groups to receive: cold blood cadioplegia (control (C) group), supplemented with either 9 mg/L propofol 10% (P group), or 10 IU/L regular insulin (I group)
Results
Propofol induced significant higher myocardial protection presented by better histopathological grading of the obtained muscle biopsies when compared to either group C ( = 0.0460) or group I ( = 0.014), lower postoperative dysrhythmia ( = 0.004), lower troponin I release (40.57 ± 8.5 vs 47.7 ± 6.22-fold increase), and more eukalemic state with lower need for K supplementation than insulin.
Conclusion
Propofol was superior to insulin in providing higher grade of myocardial protection with lower troponin I release, more steady K level and lower postoperative complications.

Keywords